Rackspace Technology, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – RXT

  • Post author:
  • Post category:Business

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Rackspace Technology, Inc. ("Rackspace" or "the Company") (NASDAQ: RXT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of…

Continue ReadingRackspace Technology, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – RXT

59th CIFF Guangzhou: Power the Next. Celebrating 30 years, CIFF Guangzhou looks ahead to a new era of design, innovation and global business

GUANGZHOU, China, Sept. 28, 2026 /PRNewswire/ -- The 59th China International Furniture Fair (CIFF Guangzhou) will be held in Guangzhou Pazhou in two phases, on March 18–21 and March 28–31, 2027, marking an important milestone: 30 years since…

Continue Reading59th CIFF Guangzhou: Power the Next. Celebrating 30 years, CIFF Guangzhou looks ahead to a new era of design, innovation and global business

Yili Shares China’s Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference

  • Post author:
  • Post category:Business

ROME, Sept. 27, 2026 /PRNewswire/ -- Yili Group presented a China-based model for whole-value-chain symbiosis at the Food and Agriculture Organization of the United Nations' (FAO) inaugural Global Conference for Actions on One Health in Agrifood Systems. One…

Continue ReadingYili Shares China’s Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

  • Post author:
  • Post category:Sales & Growth

HONG KONG, Sep. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicenter Phase III head-to-head trial evaluating cadonilimab, Akeso's first-in-class PD-1/CTLA-4…

Continue ReadingAkeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

PAINSTUDY Inc. Targets ‘Self-Medication’ Demand with Functional Muscle and Joint Patches

Functional healthcare brand leads with everyday muscle and joint care patches as it expands into a growing global wellness trendSEOUL, South Korea, Sept. 27, 2026 /PRNewswire/ -- Functional healthcare brand PAINSTUDY Inc. is expanding its market presence with a…

Continue ReadingPAINSTUDY Inc. Targets ‘Self-Medication’ Demand with Functional Muscle and Joint Patches